RecruitingNCT07388628
ARTICE® Real Data Collection & Observational Trial, Phase 4 Study
ARTISTRY - ARTICE® Therapy Registry Study
Sponsor
Artcline GmbH
Enrollment
200 participants
Start Date
Sep 25, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The objectives of this registry study are to: 1. Record real-life data related to the use of the ARTICE® therapy in sepsis subjects. 2. Further evaluate ARTICE® treatment efficacy. 3. Identify potential sub-groups, assess their risk-benefit- and safety profile. 4. Changes in SOFA score D0 to SOFA Score D7.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Subjects ≥ 18 years who are planned to receive ARTICE® treatment during their ICU stay
Exclusion Criteria1
- \-
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07388628
Related Trials
Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock
NCT0717927627 locations
Stop Sepsis Through Home Monitoring Cooperative
NCT069209791 location
Efficacy and Safety of Cytokine Adsorption and Plasma Exchange in Patients With ACLF and Sepsis
NCT065628031 location
Aminoglycosides in Early Sepsis
NCT067126415 locations
NeoDoppler: New Ultrasound Technology for Continuous Monitoring of Cerebral Circulation Pilot
NCT066462501 location